IP Library Granted Patent US 11,458,325
Granted Patent B2
US 11,458,325 · App. 16/830,607 · Granted Oct 4, 2022

Non-invasive nerve stimulation to patients

Inventors: Bruce J. Simon (Mountain Lakes, NJ); Joseph P. Errico (Warren, NJ); John T. Raffle (Austin, TX); Steven Mendez (Chester, NJ)
Assignee: ELECTROCORE, INC
A61N2/002A61H23/00A61H23/02A61H31/00A61H39/002A61N1/3601A61N1/36014A61N1/3758A61N1/3787A61N1/40A61N2/006A61N2/02A61N5/0603A61N5/0622A61N5/0625A61N7/00A61H23/004A61H23/0236A61H2201/123A61H2201/1604A61H2201/165A61H2201/1609A61N1/36114A61N2005/063A61N2005/0605A61N2007/0026
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,458,325
App. No.
16/830,607
Granted
Oct 4, 2022
Kind
B2
Abstract

Devices, systems and methods are provided for treating a disease or disorder in a patient. The methods include positioning a surface of a housing in contact with an outer skin surface of the patient and applying sufficient energy to an energy transmitter within the housing via a power supply to generate an electrical impulse at or near a vagus nerve of the patient. The electrical impulse is sufficient to modulate fibers of the vagus nerve and treat the disease or disorder.

Claims (26)

1. A method of treating a disease or disorder in a patient, the method comprising:

positioning a surface of a housing in contact with an outer skin surface of the patient, wherein the housing is coupled to a power supply and the housing comprises a magnetic coil located within an interior of the housing; and

applying a sufficient magnetic field via the power supply and the magnetic coil to generate an electrical impulse at or near a vagus nerve of the patient, wherein the electrical impulse is sufficient to modulate fibers of the vagus nerve and treat the disease or disorder.

2. The method of claim 1 , wherein the electrical impulse is sufficient to stimulate a release of catecholamines within the patient.

3. The method of claim 1 , wherein the electrical impulse is sufficient to stimulate a release of neurotransmitters within the patient.

4. The method of claim 2 , wherein the catecholamines comprise endogenous B-agonists, epinephrine or norepinephrine.

5. The method of claim 1 further comprising positioning the surface of the housing in contact with the outer skin surface of a neck of the patient.

6. The method of claim 1 , wherein the disease or disorder comprises bronchoconstriction and the electrical impulse is sufficient to cause a release of catecholamines into a circulation of the patient at concentrations sufficient to product bronchial smooth muscle relaxation.

7. The method of claim 1 , wherein the magnetic coil comprises a toroid.

8. The method of claim 1 , wherein the electrical impulse comprises a frequency from about 15 Hz to about 50 Hz.

9. The method of claim 1 , wherein the electrical impulse comprises a pulse width from about 10 to about 1,000 microseconds.

10. The method of claim 1 , wherein the housing comprises a volume of electrically conductive fluid within the interior of the housing, wherein the energy transmitter is at least partially surrounded by and in contact with a portion of the electrically conductive fluid.

11. The method of claim 10 , wherein the electrically conductive fluid comprises an electrically conductive gel.

12. A device for treating a disease or disorder in a patient, the device comprising:

a power source;

a housing coupled to the power source and having an interior, and an outer contact surface for contacting an outer skin surface of the patient;

a magnetic coil positioned within the interior of the housing; and

wherein the power source supplies energy to the magnetic coil to generate an electrical impulse at a vagus nerve of the patient when the outer contact surface of the housing is in contact with the outer skin surface of the patient, wherein the electrical impulse is sufficient to modulate fibers of the vagus nerve to treat the disease or disorder, wherein the magnetic coil comprises a toroid.

13. The device of claim 12 , wherein the electrical impulse is sufficient to stimulate a release of catecholamines within the patient.

14. The device of claim 12 , wherein the electrical impulse is sufficient to stimulate a release of neurotransmitters within the patient.

15. The device of claim 13 , wherein the catecholamines comprise endogenous B-agonists, epinephrine or norepinephrine.

16. The device of claim 12 wherein the disease or disorder comprises bronchoconstriction and the electrical impulse is sufficient to cause a release of catecholamines into a circulation of the patient at concentrations sufficient to product bronchial smooth muscle relaxation.

17. The device of claim 12 , wherein the power source is located within the interior of the housing.

18. The device of claim 12 , wherein the interior of the housing is at least partially filled with an electrically conductive fluid that is in contact with, and at least partially surrounds, the energy transmitter.

19. The device of claim 12 , wherein the electrical impulse comprises a frequency from about 15 Hz to about 50 Hz.

20. The device of claim 12 , wherein the electrical impulse comprises a pulse width from about 10 to about 1,000 microseconds.

Assignments (1)
SECURITY INTEREST Recorded Aug 12, 2025
From: ELECTROCORE, INC.
To: AVENUE VENTURE OPPORTUNITIES FUND II, L.P.
Reel/Frame 072452/0559 →
Continuity (6)
Continuation 16030368 · Jul 9, 2018
Continuation 15419058 · Jan 30, 2017
Continuation 15145767 · May 30, 2016
Continuation 14337612 · Jul 22, 2014
Division 12859568 · Aug 19, 2010
Related Publication 20200222708A1 · Jul 16, 2020
Cited By (1)
US 12,357,817